Dr. Walley is the CEO of NEXT Life Sciences, a reproductive health platform company with flagship product Plan ATM, a non-hormonal, long-lasting, reversible on demand male contraceptive.
Dr. Walley has over 30 years of Life Science business experience, having served as an Executive at Procter & Gamble, Gillette/Oral-B Laboratories and Arm & Hammer and CEO of early-stage Pharma/Biotech companies. Darlene is very skilled in the launch of products/companies, raising capital and improving performance. Darlene works with start-up companies, investment firms and serves on the Board of Directors of several companies. Dr. Walley has led CRO’s and launched over 100 products in the OTC, Rx and Medical Device areas. She has raised over $100M with 5 successful exits totaling over $1B.
She holds 12 patents, largely dealing with consumer health products, and over 13 publications.
Dr. Walley received a BA in Chemistry from Case Western Reserve University and a PhD in Organic Chemistry from the University of Cincinnati.